Description
NAGA Antibody | 23-989 | Gentaur UK, US & Europe Distribution
Host: Rabbit
Reactivity: Human, Mouse, Rat
Homology: N/A
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 312-411 of human NAGA (NP_000253.1) .
Research Area: Cancer, Signal Transduction
Tested Application: WB
Application: WB: 1:500 - 1:2000
Specificiy: N/A
Positive Control 1: HL-60
Positive Control 2: Mouse liver
Positive Control 3: Mouse kidney
Positive Control 4: Mouse lung
Positive Control 5: Rat testis
Positive Control 6: N/A
Molecular Weight: Observed: 46kDa
Validation: N/A
Isoform: N/A
Purification: Affinity purification
Clonality: Polyclonal
Clone: N/A
Isotype: IgG
Conjugate: Unconjugated
Physical State: Liquid
Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Concentration: N/A
Storage Condition: Store at -20˚C. Avoid freeze / thaw cycles.
Alternate Name: D22S674, GALB, alpha-N-acetylgalactosaminidase, Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B) , N-acetylgalactosaminidase, alpha-, alpha-galactosidase B
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease) .